Facial Plast Surg 2023; 39(06): 674-678
DOI: 10.1055/a-2111-9203
Original Article

Opioid-Sparing Pain Control after Rhinoplasty: Updated Review of the Literature

1   Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts
,
Lucy J. Xu
1   Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts
,
Linda N. Lee
1   Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts
› Author Affiliations

Abstract

Rhinoplasty is one of the most performed elective surgeries, and given the opioid crisis, increasing research and studies are focused on successful pain control with multimodality opioid-sparing techniques, such as acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and gabapentin. Although limiting overuse of opioids is critical, this cannot be at the expense of inadequate pain control, particularly as insufficient pain control can be correlated with patient dissatisfaction and the postoperative experience in elective surgery. There is likely significant opioid overprescription, as patients often report taking less than 50% of their prescribed opioids. Furthermore, excess opioids provide opportunities for misuse and opioid diversion if not disposed of properly. To optimize postoperative pain control and minimize opioid requirements, interventions must occur at the preoperative, intraoperative, and postoperative time points. Preoperative counseling is imperative to set expectations for pain and to screen for predisposing factors for opioid misuse. Intraoperatively, use of local nerve blocks and long-acting analgesia in conjunction with modified surgical techniques can lead to prolonged pain control. Postoperatively, pain should be managed with a multimodal approach, incorporating acetaminophen, NSAIDs, and potentially gabapentin with opioids reserved for rescue analgesia. Rhinoplasty represents a category of short-stay, low/medium pain, and elective procedures highly susceptible to overprescription and consequently, are readily amenable to opioid minimization through standardized perioperative interventions. Recent literature on regimens and interventions to help limit opioids after rhinoplasty are reviewed and discussed here.



Publication History

Accepted Manuscript online:
16 June 2023

Article published online:
24 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019. MMWR Morb Mortal Wkly Rep 2021; 70 (06) 202-207
  • 2 Steyaert A, Lavand'homme P. Postoperative opioids: let us take responsibility for the possible consequences. Eur J Anaesthesiol 2013; 30 (02) 50-52
  • 3 Jiang X, Orton M, Feng R. et al. Chronic opioid usage in surgical patients in a large academic center. Ann Surg 2017; 265 (04) 722-727
  • 4 Lawal OD, Gold J, Murthy A. et al. Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis. JAMA Netw Open 2020; 3 (06) e207367
  • 5 Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Ann Intern Med 2017; 167 (05) 293-301
  • 6 Manchikanti L, Helm II S, Fellows B. et al. Opioid epidemic in the United States. Pain Physician 2012; 15 (3, Suppl): ES9-ES38
  • 7 Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev 2011; 30 (03) 264-270
  • 8 Gadkaree SK, Shaye DA, McCarty JC. et al. Prospective qualitative multidimensional assessment of the postoperative rhinoplasty experience. Facial Plast Surg Aesthet Med 2020; 22 (03) 213-218
  • 9 Marshall RV, Rivers NJ, Manickavel S, Grayson JW, Cox AJ. Postoperative opioid use in rhinoplasty procedures: a standardized regimen. Facial Plast Surg 2021; 37 (01) 110-116
  • 10 Frants A, Garber D, Lafer MP. et al. Prospective randomized trial comparing opioids versus nonsteroidal antiinflammatory drugs for postoperative analgesia in outpatient rhinoplasty. Plast Reconstr Surg 2021; 147 (01) 56-62
  • 11 Justicz N, Gadkaree SK, Yamasaki A, Lindsay RW. Defining typical acetaminophen and narcotic usage in the postoperative rhinoplasty patient. Laryngoscope 2021; 131 (01) 48-53
  • 12 Schwartz MA, Naples JG, Kuo CL, Falcone TE. Opioid prescribing patterns among otolaryngologists. Otolaryngol Head Neck Surg 2018; 158 (05) 854-859
  • 13 Dang S, Duffy A, Li JC. et al. Postoperative opioid-prescribing practices in otolaryngology: a multiphasic study. Laryngoscope 2020; 130 (03) 659-665
  • 14 Murphey AW, Munawar S, Nguyen SA, Meyer TA, O'Rourke AK. Opioid prescribing patterns within otolaryngology. World J Otorhinolaryngol Head Neck Surg 2019; 5 (02) 112-116
  • 15 Patel S, Sturm A, Bobian M, Svider PF, Zuliani G, Kridel R. Opioid use by patients after rhinoplasty. JAMA Facial Plast Surg 2018; 20 (01) 24-30
  • 16 Chang MT, Lalakea ML, Shepard K, Saste M, Munoz A, Amoils M. Implementation of a standardized perioperative pain management protocol to reduce opioid prescriptions in otolaryngologic surgery. Otolaryngol Head Neck Surg 2022; 167 (04) 657-663
  • 17 Gadkaree SK, Shaye DA, Occhiogrosso J, Lee LN. Association between pain and patient satisfaction after rhinoplasty. JAMA Facial Plast Surg 2019; 21 (06) 475-479
  • 18 Jandali D, Barrera JE. Equivocal pain scores one week after rhinoplasty: synthetic opioid versus neuropathic analgesic. Facial Plast Surg Aesthet Med 2022; 24 (01) 69-70
  • 19 Jawad BA, Lam KK, Cecola CF, McCoul ED. Opioid use after elective otolaryngologic surgery at a teaching institution. Ochsner J 2022; 22 (01) 15-21
  • 20 Kim M, Kacker A, Kutler DI. et al. Pain and opioid analgesic use after otorhinolaryngologic surgery. Otolaryngol Head Neck Surg 2020; 163 (06) 1178-1185
  • 21 Kshirsagar RS, Xiao C, Luetzenberg FS, Luu L, Jiang N. Reducing opioid use in post-operative otolaryngology patients: a quality improvement project. Am J Otolaryngol 2021; 42 (04) 102991
  • 22 Locketz GD, Brant JD, Adappa ND. et al. Postoperative opioid use in sinonasal surgery. Otolaryngol Head Neck Surg 2019; 160 (03) 402-408
  • 23 Neighbors CP, Noller MW, Avillion MP. et al. Implementing a protocol to reduce opioid prescriptions in military otolaryngology: a quality improvement initiative. Mil Med 2022; 187 (1-2): e154-e159
  • 24 Rock AN, Akakpo K, Cheresnick C. et al. Postoperative prescriptions and corresponding opioid consumption after septoplasty or rhinoplasty. Ear Nose Throat J 2021; 100 (5_suppl): 462S-466S
  • 25 Sclafani AP, Kim M, Kjaer K, Kacker A, Tabaee A. Postoperative pain and analgesic requirements after septoplasty and rhinoplasty. Laryngoscope 2019; 129 (09) 2020-2025
  • 26 Sethi RKV, Lee LN, Quatela OE, Richburg KG, Shaye DA. Opioid prescription patterns after rhinoplasty. JAMA Facial Plast Surg 2019; 21 (01) 76-77
  • 27 Kennedy-Hendricks A, Gielen A, McDonald E, McGinty EE, Shields W, Barry CL. Medication sharing, storage, and disposal practices for opioid medications among US adults. JAMA Intern Med 2016; 176 (07) 1027-1029
  • 28 Newberry CI, McCrary HC, Cerrati EW. The efficacy of oral celecoxib following surgical rhinoplasty. Facial Plast Surg Aesthet Med 2020; 22 (02) 100-104
  • 29 Anne S, Mims JW, Tunkel DE. et al. Clinical practice guideline: opioid prescribing for analgesia after common otolaryngology operations. Otolaryngol Head Neck Surg 2021; 164 (2_suppl): S1-S42
  • 30 Sugai DY, Deptula PL, Parsa AA, Don Parsa F. The importance of communication in the management of postoperative pain. Hawaii J Med Public Health 2013; 72 (06) 180-184
  • 31 van Dijk JF, van Wijck AJ, Kappen TH, Peelen LM, Kalkman CJ, Schuurmans MJ. The effect of a preoperative educational film on patients' postoperative pain in relation to their request for opioids. Pain Manag Nurs 2015; 16 (02) 137-145
  • 32 Çelik EC, Kara D, Koc E, Yayik AM. The comparison of single-dose preemptive intravenous ibuprofen and paracetamol on postoperative pain scores and opioid consumption after open septorhinoplasty: a randomized controlled study. Eur Arch Otorhinolaryngol 2018; 275 (09) 2259-2263
  • 33 Salama ER, Amer AF. The effect of pre-emptive gabapentin on anaesthetic and analgesic requirements in patients undergoing rhinoplasty: a prospective randomised study. Indian J Anaesth 2018; 62 (03) 197-201
  • 34 Demirhan A, Tekelioglu UY, Akkaya A. et al. Effect of pregabalin and dexamethasone addition to multimodal analgesia on postoperative analgesia following rhinoplasty surgery. Aesthetic Plast Surg 2013; 37 (06) 1100-1106
  • 35 Degirmenci N, Ozdem A, Uysal H. et al. The effect of sphenopalatine ganglion block on the postoperative pain in patients undergoing septorhinoplasty. Ann Otol Rhinol Laryngol 2020; 129 (07) 722-726
  • 36 Bashir MM, Shahzad MA, Yousaf MN, Khan BA, Khan FA. Comparison of postoperative pain relief by intercostal block between pre-rib harvest and post-rib harvest groups. J Coll Physicians Surg Pak 2014; 24 (01) 43-46
  • 37 Chen C, Xiang G, Liu Q. et al. Ultrasound-guided serratus anterior plane block, along with improved parasternal block, is superior to serratus anterior plane block alone in relieving pain for rhinoplasty with autologous costal cartilage. Aesthetic Plast Surg 2022
  • 38 Özücer B, Dinç ME, Paltura C. et al. Association of autologous costal cartilage harvesting technique with donor-site pain in patients undergoing rhinoplasty. JAMA Facial Plast Surg 2018; 20 (02) 136-140
  • 39 Dong W, Wang X, Wang H. et al. A prospective study of multimodal cocktail intercostal injection for chest pain relief after costal cartilage harvest for rhinoplasty. Br J Oral Maxillofac Surg 2022; 60 (06) 841-846
  • 40 Guoyu J, Tao W, Xi Y. Application of methylene blue combined with ropivacaine intercostal nerve block in postoperative analgesia of autologous costal cartilage augmentation rhinoplasty. Anaesthesiologie 2022; 71 (Suppl. 02) 233-239
  • 41 Quintero GC. Review about gabapentin misuse, interactions, contraindications and side effects. J Exp Pharmacol 2017; 9: 13-21
  • 42 Aulet RM, Trieu V, Landrigan GP, Millay DJ. Changes in opioid prescribing habits for patients undergoing rhinoplasty and septoplasty. JAMA Facial Plast Surg 2019; 21 (06) 487-490
  • 43 Straughan DM, Lindsey Jr JT, McCarthy M, Legendre D, Lindsey Sr JT. Enhanced recovery after surgery protocol with ultrasound-guided regional blocks in outpatient plastic surgery patients leads to decreased opioid prescriptions and consumption. Aesthet Surg J 2021; 41 (08) NP1105-NP1114